{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:41:30Z","timestamp":1792748490311,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008485","name":"Schweizerische Akademie der Medizinischen Wissenschaften","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018381","name":"Stiftung f\u00fcr Leberkrankheiten","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005688","name":"Gottfried und Julia Bangerter-Rhyner-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.dld.2022.10.009","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T08:36:53Z","timestamp":1667896613000},"page":"326-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Non-invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII \u2013 an update"],"prefix":"10.1016","volume":"55","author":[{"given":"Daniel","family":"Segna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuly P.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi F.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana G.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4562-9016","authenticated-orcid":false,"given":"Annalisa","family":"Berzigotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dld.2022.10.009_bib0001","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.dld.2022.10.009_bib0002","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2022.10.009_bib0003","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cld.2021.01.005","article-title":"Noninvasive detection of clinically significant portal hypertension in compensated advanced chronic liver disease","volume":"25","author":"Vuille-Lessard","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1155\/2011\/954812","article-title":"Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension","volume":"31","author":"Berzigotti","year":"2011","journal-title":"Dis Markers"},{"issue":"21","key":"10.1016\/j.dld.2022.10.009_bib0005","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.dld.2022.10.009_bib0006","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0007","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000374100","article-title":"Clinical evaluation and prognosis","volume":"33","author":"Hern\u00e1ndez-Gea","year":"2015","journal-title":"Dig Dis"},{"issue":"2","key":"10.1016\/j.dld.2022.10.009_bib0008","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.dld.2022.10.009_bib0009","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","article-title":"Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis","volume":"50","author":"Ripoll","year":"2009","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"issue":"10181","key":"10.1016\/j.dld.2022.10.009_bib0011","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0012","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2022.10.009_bib0013","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-017-0966-6","article-title":"Advances and challenges in cirrhosis and portal hypertension","volume":"15","author":"Berzigotti","year":"2017","journal-title":"BMC Med"},{"issue":"9930","key":"10.1016\/j.dld.2022.10.009_bib0014","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.dld.2022.10.009_bib0015","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/j.cgh.2020.04.018","article-title":"Noninvasive markers of portal hypertension detect decompensation in overweight or obese patients with compensated advanced chronic liver disease","volume":"18","author":"Mendoza","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0016","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2013.11.016","article-title":"Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest\u2122) and transient elastography (FibroScan\u00ae)","volume":"60","author":"Poynard","year":"2014","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0017","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.cgh.2020.06.045","article-title":"Monitoring Occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease","volume":"19","author":"Petta","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2022.10.009_bib0018","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jhep.2021.05.037","article-title":"Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease","volume":"75","author":"Rasmussen","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2022.10.009_bib0019","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.29179","article-title":"Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis","volume":"67","author":"Herrmann","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.dld.2022.10.009_bib0020","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dld.2022.10.009_bib0021","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/gutjnl-2020-323419","article-title":"Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease","volume":"71","author":"Trebicka","year":"2022","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0022","doi-asserted-by":"crossref","first-page":"723","DOI":"10.14309\/ajg.0000000000000994","article-title":"Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease","volume":"116","author":"Pons","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0023","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.31462","article-title":"Noninvasive risk stratification after HCV eradication in patients with advanced chronic liver disease","volume":"73","author":"Semmler","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0024","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2019.10.005","article-title":"Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals","volume":"72","author":"Pons","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2022.10.009_bib0025","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","article-title":"Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis","volume":"154","author":"Sim\u00f3n-Talero","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dld.2022.10.009_bib0026","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ultrasmedbio.2016.07.025","article-title":"A meta-analysis for the diagnostic performance of transient elastography for clinically significant portal hypertension","volume":"43","author":"You","year":"2017","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"10.1016\/j.dld.2022.10.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149230","article-title":"The VITRO score (Von Willebrand factor antigen\/thrombocyte ratio) as a new marker for clinically significant portal hypertension in comparison to other non-invasive parameters of fibrosis including ELF test","volume":"11","author":"Hametner","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dld.2022.10.009_bib0028","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12876-015-0414-z","article-title":"Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study","volume":"15","author":"Zykus","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2022.10.009_bib0029","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/a-0731-0178","article-title":"Reliability of transient elastography-based liver stiffness for diagnosing portal hypertension in patients with alcoholic liver disease: a diagnostic meta-analysis with specific cut-off values","volume":"41","author":"Song","year":"2020","journal-title":"Ultraschall Med"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3748\/wjg.v23.i4.687","article-title":"Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: a study of 326 patients from India","volume":"23","author":"Kumar","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0031","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"Easl clinical practice guidelines (Cpgs) on non-invasive tests for evaluation of liver disease severity and prognosis- 2021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2022.10.009_bib0032","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/hep.28824","article-title":"Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the \"Anticipate\" study","volume":"64","author":"Abraldes","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0033","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MOG.0000000000000824","article-title":"Noninvasive assessment oesophageal varices: impact of the Baveno VI criteria","volume":"38","author":"Bai","year":"2022","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0034","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2010.01.004","article-title":"Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension","volume":"52","author":"Mejias","year":"2010","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2022.10.009_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2012.11.015","article-title":"When the spleen gets tough, the varices get going","volume":"144","author":"Cast\u00e9ra","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0036","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1148\/radiol.12111046","article-title":"Liver and spleen stiffness in patients with extrahepatic portal vein obstruction","volume":"263","author":"Sharma","year":"2012","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.dld.2022.10.009_bib0037","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2021.09.029","article-title":"Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: is it real and how to measure it?","volume":"76","author":"Baffy","year":"2022","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.dld.2022.10.009_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165786","article-title":"Spleen stiffness is superior to liver stiffness for predicting esophageal varices in chronic liver disease: a meta-analysis","volume":"11","author":"Ma","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0039","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clinre.2017.11.002","article-title":"Performance of spleen stiffness measurement in prediction of clinical significant portal hypertension: a meta-analysis","volume":"42","author":"Song","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2018.10.018","article-title":"Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices","volume":"70","author":"Kim","year":"2019","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2022.10.009_bib0041","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s12072-020-10062-w","article-title":"Spleen stiffness measurement for assessing the response to \u03b2-blockers therapy for high-risk esophageal varices patients","volume":"14","author":"Marasco","year":"2020","journal-title":"Hepatol Int"},{"issue":"10","key":"10.1016\/j.dld.2022.10.009_bib0042","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4254\/wjh.v10.i10.731","article-title":"Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients","volume":"10","author":"Ravaioli","year":"2018","journal-title":"World J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0043","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/j.gastro.2012.05.035","article-title":"Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis","volume":"143","author":"Colecchia","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dld.2022.10.009_bib0044","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1148\/radiol.14141210","article-title":"Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis","volume":"275","author":"Elkrief","year":"2015","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.dld.2022.10.009_bib0045","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2014.02.024","article-title":"Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study","volume":"60","author":"Colecchia","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2022.10.009_bib0046","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jhep.2018.04.023","article-title":"A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease","volume":"69","author":"Colecchia","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2022.10.009_bib0047","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/liv.14228","article-title":"A novel spleen-dedicated stiffness measurement by FibroScan\u00ae improves the screening of high-risk oesophageal varices","volume":"40","author":"Stefanescu","year":"2020","journal-title":"Liver Int"},{"issue":"11","key":"10.1016\/j.dld.2022.10.009_bib0048","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.cgh.2016.10.041","article-title":"Measurement of spleen stiffness with acoustic radiation force impulse imaging predicts mortality and hepatic decompensation in patients with liver cirrhosis","volume":"15","author":"Takuma","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2022.10.009_bib0049","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/ajg.2013.119","article-title":"Spleen stiffness in patients with cirrhosis in predicting esophageal varices","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0050","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0051","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2020.09.034","article-title":"Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis","volume":"74","author":"Wang","year":"2021","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.dld.2022.10.009_bib0052","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/jvh.12114","article-title":"Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis","volume":"20","author":"Calvaruso","year":"2013","journal-title":"J Viral Hepat"},{"issue":"8","key":"10.1016\/j.dld.2022.10.009_bib0053","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.ultrasmedbio.2018.03.028","article-title":"A novel fibroscan examination dedicated to spleen stiffness measurement","volume":"44","author":"Bastard","year":"2018","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0054","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2022.10.009_bib0055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","author":"European Association for the Study of the Liver","year":"2021","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.dld.2022.10.009_bib0056","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.dld.2016.06.019","article-title":"Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease","volume":"48","author":"Pons","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.dld.2022.10.009_bib0057","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jhep.2020.06.007","article-title":"Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease","volume":"73","author":"Hagstr\u00f6m","year":"2020","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.dld.2022.10.009_bib0058","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.cgh.2018.12.031","article-title":"Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2022.10.009_bib0059","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1053\/j.gastro.2020.12.003","article-title":"The association of histologic and noninvasive tests with adverse clinical and patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0060","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","article-title":"Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis","volume":"146","author":"Corpechot","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dld.2022.10.009_bib0061","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.25599","article-title":"Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dld.2022.10.009_bib0062","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.30664","article-title":"The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials","volume":"70","author":"Sanyal","year":"2019","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.dld.2022.10.009_bib0063","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.cgh.2021.10.023","article-title":"Decompensation in advanced nonalcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels than in patients with viral disease","volume":"20","author":"Bassegoda","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2022.10.009_bib0064","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MEG.0000000000000825","article-title":"Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis","volume":"29","author":"Sourianarayanane","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.dld.2022.10.009_bib0065","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.cgh.2018.12.038","article-title":"Patients with signs of advanced liver disease and clinically significant portal hypertension do not necessarily have cirrhosis","volume":"17","author":"Rodrigues","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2022.10.009_bib0066","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jhep.2020.10.011","article-title":"Patients with NAFLD do not have severe portal hypertension in the absence of cirrhosis","volume":"74","author":"Moga","year":"2021","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0067","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2020.10.003","article-title":"Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis","volume":"74","author":"Ferrusqu\u00eda-Acosta","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2022.10.009_bib0068","doi-asserted-by":"crossref","first-page":"e2008","DOI":"10.1210\/clinem\/dgab933","article-title":"Obesity modifies the performance of fibrosis biomarkers in nonalcoholic fatty liver disease","volume":"107","author":"Qadri","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.dld.2022.10.009_bib0069","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jim-2018-000864","article-title":"Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus","volume":"67","author":"Bril","year":"2019","journal-title":"J Investig Med"},{"issue":"2","key":"10.1016\/j.dld.2022.10.009_bib0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/dc19-1071","article-title":"Performance of plasma biomarkers and diagnostic panels for nonalcoholic steatohepatitis and advanced fibrosis in patients with type 2 diabetes","volume":"43","author":"Bril","year":"2020","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0071","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/j.gastro.2022.06.073","article-title":"Liver stiffness on magnetic resonance elastography and the MEFIB index and liver-related outcomes in nonalcoholic fatty liver disease: a systematic review and meta-analysis of individual participants","volume":"163","author":"Ajmera","year":"2022","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.dld.2022.10.009_bib0072","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/hep.31588","article-title":"A model based on noninvasive markers predicts very low hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis","volume":"72","author":"Alonso L\u00f3pez","year":"2020","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.dld.2022.10.009_bib0073","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/jvh.13587","article-title":"Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study","volume":"28","author":"Knop","year":"2021","journal-title":"J Viral Hepat"},{"issue":"7","key":"10.1016\/j.dld.2022.10.009_bib0074","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/jvh.13280","article-title":"Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy-results from the German hepatitis C-registry","volume":"27","author":"Knop","year":"2020","journal-title":"J Viral Hepat"},{"issue":"5","key":"10.1016\/j.dld.2022.10.009_bib0075","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1053\/j.gastro.2017.07.016","article-title":"Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis","volume":"153","author":"Lens","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0076","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","volume":"65","author":"Mandorfer","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2022.10.009_bib0077","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.29557","article-title":"Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C","volume":"67","author":"Mauro","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.dld.2022.10.009_bib0078","doi-asserted-by":"crossref","first-page":"e13334","DOI":"10.1111\/ctr.13334","article-title":"Longitudinal assessment of hepatic fibrosis in responders to direct-acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methods","volume":"32","author":"Omar","year":"2018","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.dld.2022.10.009_bib0079","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.dld.2018.02.010","article-title":"Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals","volume":"50","author":"Ravaioli","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.dld.2022.10.009_bib0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.27069","article-title":"Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C","volume":"60","author":"Vergniol","year":"2014","journal-title":"Hepatology"},{"issue":"11\u201312","key":"10.1016\/j.dld.2022.10.009_bib0081","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/apt.16092","article-title":"Fibroscan liver stiffness after anti-viral treatment for hepatitis C is independently associated with adverse outcomes","volume":"52","author":"Vutien","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.dld.2022.10.009_bib0082","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1111\/liv.15058","article-title":"Elastography is unable to exclude cirrhosis after sustained virological response in HCV-infected patients with advanced chronic liver disease","volume":"41","author":"Broquetas","year":"2021","journal-title":"Liver Int"},{"issue":"22","key":"10.1016\/j.dld.2022.10.009_bib0083","first-page":"03056-2","article-title":"Non-invasive tests for clinically significant portal hypertension after HCV cure","volume":"S0168-8278","author":"Semmler","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2022.10.009_bib0084","doi-asserted-by":"crossref","first-page":"11681","DOI":"10.1038\/s41598-021-91099-1","article-title":"Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes","volume":"11","author":"Piedade","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.dld.2022.10.009_bib0085","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jhep.2021.11.025","article-title":"HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease","volume":"76","author":"Semmler","year":"2022","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.dld.2022.10.009_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101773","article-title":"Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus","volume":"46","author":"Leroy","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"9","key":"10.1016\/j.dld.2022.10.009_bib0087","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.cgh.2020.08.064","article-title":"Hepatic decompensation in cirrhotic patients receiving antiviral therapy for chronic hepatitis B","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2022.10.009_bib0088","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/liv.12020","article-title":"Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy","volume":"33","author":"Kim","year":"2013","journal-title":"Liver Int"},{"issue":"21","key":"10.1016\/j.dld.2022.10.009_bib0089","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.21037\/atm-21-3142","article-title":"Dynamic monitoring with shear wave elastography predicts outcomes of chronic hepatitis B patients with decompensated cirrhosis","volume":"9","author":"Ye","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.dld.2022.10.009_bib0090","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000001887","article-title":"A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease","author":"Dajti","year":"2022","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822007435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822007435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:22:27Z","timestamp":1761625347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865822007435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1590865822007435"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2022.10.009","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII \u2013 an update","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2022.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}